Better Therapeutics, Inc. (BTTX)
NASDAQ: BTTX · IEX Real-Time Price · USD
1.47
-0.07 (-4.55%)
At close: May 20, 2022 4:00 PM
1.46
-0.01 (-0.68%)
After-hours:May 20, 2022 7:56 PM EDT
Cash Flow Statement (Trailing)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Period Ended | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -44.67 | -40.34 | -28.19 | -17.9 | -10.3 | -6.39 | - | - | -5.78 |
| Depreciation & Amortization | - | 1.62 | - | 0.58 | - | 0.08 | - | - | 0.07 |
| Share-Based Compensation | - | 0.65 | - | 0.27 | - | 0.23 | - | - | 0.08 |
| Other Operating Activities | 44.67 | 7.25 | 28.19 | 5.86 | 10.3 | 0.31 | 0 | 0 | -0.59 |
| Operating Cash Flow | - | -30.82 | - | -11.2 | - | -5.77 | - | - | -6.22 |
| Capital Expenditures | - | -1.07 | - | -1.71 | - | -2.31 | - | - | -2.74 |
| Investing Cash Flow | - | -1.07 | - | -1.71 | - | -2.31 | - | - | -2.74 |
| Share Issuance / Repurchase | - | 44.18 | - | 0 | - | 0 | - | - | 0 |
| Debt Issued / Paid | - | 28.16 | - | 14.53 | - | 7.45 | - | - | 5 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.7 |
| Financing Cash Flow | - | 72.33 | - | 14.53 | - | 7.45 | - | - | 8.7 |
| Net Cash Flow | - | 40.44 | - | 1.62 | - | -0.63 | - | - | -0.25 |
| Free Cash Flow | - | -31.89 | - | -12.91 | - | -8.08 | - | - | -8.95 |
| Free Cash Flow Margin | - | - | - | 184414.29% | - | - | - | - | -49738.89% |
| Free Cash Flow Per Share | - | -2.46 | - | -2.47 | - | -0.81 | - | - | -1.89 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).